During the past decade, Calgary COPD & Asthma Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Calgary COPD & Asthma Program" are "Asthma" (2 trials). Many other conditions were trialed in "Calgary COPD & Asthma Program" in a lesser frequency.

Most popular intervention types in "Calgary COPD & Asthma Program" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASM8" (1 trials), "MEDI528 50 mg" (1 trials), "PLACEBO" (1 trials) and "TPI ASM8" (1 trials). Other intervention names were less common.

The vast majority of trials in "Calgary COPD & Asthma Program" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Calgary COPD & Asthma Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Calgary COPD & Asthma Program, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Calgary COPD & Asthma Program, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".